Low blood levels of vitamin B6 — found in certain foods and essential for metabolism and immune function in the…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Twice-daily treatment with volixibat, Mirum Pharmaceuticals’ oral investigational therapy for primary sclerosing cholangitis (PSC) significantly outperformed a placebo…
In a rat model of segmental cholestasis, a condition in which bile flow is blocked in certain areas of…
CHOLESTASIS
NewsNew mouse model could help guide PFIC3 treatment research
Researchers have developed a new mouse model of progressive familial intrahepatic cholestasis type 3 (PFIC3) that more closely mimics…
FATTY LIVER DISEASE
News‘Zombie’ immune cells may help drive steatotic liver disease, study shows
Clearing senescent macrophages, a type of damaged immune cell that doesn’t die off as it should, reduced inflammation and reversed…
HEPATITIS
NewsFDA puts pevifoscorvir sodium for hepatitis B on fast track
The U.S. Food and Drug Administration (FDA) has granted fast-track designation to pevifoscorvir sodium, Aligos Therapeutics‘ oral therapy candidate…
A genetic susceptibility to gestational diabetes mellitus (GDM), a common pregnancy complication marked by intolerance to blood sugar due to…
FATTY LIVER DISEASE
NewsHeavy episodic drinking raises odds of liver scarring in MASLD patients
People with metabolic dysfunction-associated steatotic liver disease (MASLD) who drink heavily at least once a month face higher odds…
HEPATITIS
NewsTreating hepatitis C in jails seen as key to stopping spread
Offering jail-based hepatitis C programs that include testing, treatment, and post-release support could cut new hepatitis C virus (HCV)…
A late-stage clinical trial assessing the safety and effectiveness of Mirum Pharmaceuticals’ brelovitug for adults with chronic hepatitis…